AIMS/HYPOTHESIS: To assess the feasibility and effectiveness of an active real-life primary care lifestyle intervention in preventing type 2 diabetes within a high-risk Mediterranean population. METHODS: A prospective cohort study was performed in the setting of Spanish primary care. White-European individuals without diabetes aged 45-75 years (n = 2,054) were screened using the Finnish Diabetes Risk Score (FINDRISC) and a subsequent 2 h OGTT. Where feasible, high-risk individuals who were identified were allocated sequentially to standard care, a group-based or an individual level intervention (intensive reinforced DE-PLAN [Diabetes in Europe-Prevention using Lifestyle, Physical Activity and Nutritional] intervention). The primary outcome was the development of diabetes according to WHO criteria. Analyses after 4-year follow-up were performed based on the intention-to-treat principle with comparison of standard care and the combined intervention groups. RESULTS: The standard care (n = 219) and intensive intervention (n = 333) groups were comparable in age (62.0/62.2 years), sex (64.4/68.2% women), BMI (31.3/31.2 kg/m(2)), FINDRISC score (16.2/15.8 points), fasting (5.3/5.2 mmol/l), 2 h plasma glucose (7.1/6.9 mmol/l) and self-reported interest to make lifestyle changes at baseline. Diabetes was diagnosed in 124 individuals: 63 (28.8%) in the standard care group and 61 (18.3%) in the intensive intervention group. During a 4.2-year median follow-up, the incidences of diabetes were 7.2 and 4.6 cases per 100 person-years, respectively (36.5% relative risk reduction, p < 0.005). The number of participants needed to be treated by intensive intervention for 4 years to reduce one case of diabetes was 9.5. CONCLUSIONS/ INTERPRETATION: Intensive lifestyle intervention is feasible in a primary care setting and substantially reduces diabetes incidence among high-risk individuals. CLINICAL TRIAL REGISTRATION: ClinicalTrial.gov NCT01519505. FUNDING: Commission of the European Communities, Institute of Health Carlos III, Spanish Ministry of Health and Department of Health, Generalitat de Catalunya.
AIMS/HYPOTHESIS: To assess the feasibility and effectiveness of an active real-life primary care lifestyle intervention in preventing type 2 diabetes within a high-risk Mediterranean population. METHODS: A prospective cohort study was performed in the setting of Spanish primary care. White-European individuals without diabetes aged 45-75 years (n = 2,054) were screened using the Finnish Diabetes Risk Score (FINDRISC) and a subsequent 2 h OGTT. Where feasible, high-risk individuals who were identified were allocated sequentially to standard care, a group-based or an individual level intervention (intensive reinforced DE-PLAN [Diabetes in Europe-Prevention using Lifestyle, Physical Activity and Nutritional] intervention). The primary outcome was the development of diabetes according to WHO criteria. Analyses after 4-year follow-up were performed based on the intention-to-treat principle with comparison of standard care and the combined intervention groups. RESULTS: The standard care (n = 219) and intensive intervention (n = 333) groups were comparable in age (62.0/62.2 years), sex (64.4/68.2% women), BMI (31.3/31.2 kg/m(2)), FINDRISC score (16.2/15.8 points), fasting (5.3/5.2 mmol/l), 2 h plasma glucose (7.1/6.9 mmol/l) and self-reported interest to make lifestyle changes at baseline. Diabetes was diagnosed in 124 individuals: 63 (28.8%) in the standard care group and 61 (18.3%) in the intensive intervention group. During a 4.2-year median follow-up, the incidences of diabetes were 7.2 and 4.6 cases per 100 person-years, respectively (36.5% relative risk reduction, p < 0.005). The number of participants needed to be treated by intensive intervention for 4 years to reduce one case of diabetes was 9.5. CONCLUSIONS/ INTERPRETATION: Intensive lifestyle intervention is feasible in a primary care setting and substantially reduces diabetes incidence among high-risk individuals. CLINICAL TRIAL REGISTRATION: ClinicalTrial.gov NCT01519505. FUNDING: Commission of the European Communities, Institute of Health Carlos III, Spanish Ministry of Health and Department of Health, Generalitat de Catalunya.
Authors: J Lindström; A Neumann; K E Sheppard; A Gilis-Januszewska; C J Greaves; U Handke; P Pajunen; S Puhl; A Pölönen; A Rissanen; M Roden; T Stemper; V Telle-Hjellset; J Tuomilehto; D Velickiene; P E Schwarz; T Acosta; M Adler; A AlKerwi; N Barengo; R Barengo; J M Boavida; K Charlesworth; V Christov; B Claussen; X Cos; E Cosson; S Deceukelier; V Dimitrijevic-Sreckovic; P Djordjevic; P Evans; A-M Felton; M Fischer; R Gabriel-Sanchez; A Gilis-Januszewska; M Goldfracht; J L Gomez; C J Greaves; M Hall; U Handke; H Hauner; J Herbst; N Hermanns; L Herrebrugh; C Huber; U Hühmer; J Huttunen; A Jotic; Z Kamenov; S Karadeniz; N Katsilambros; M Khalangot; K Kissimova-Skarbek; D Köhler; V Kopp; P Kronsbein; B Kulzer; D Kyne-Grzebalski; K Lalic; N Lalic; R Landgraf; Y H Lee-Barkey; S Liatis; J Lindström; K Makrilakis; C McIntosh; M McKee; A C Mesquita; D Misina; F Muylle; A Neumann; A C Paiva; P Pajunen; B Paulweber; M Peltonen; L Perrenoud; A Pfeiffer; A Pölönen; S Puhl; F Raposo; T Reinehr; A Rissanen; C Robinson; M Roden; U Rothe; T Saaristo; J Scholl; P E Schwarz; K E Sheppard; S Spiers; T Stemper; B Stratmann; J Szendroedi; Z Szybinski; T Tankova; V Telle-Hjellset; G Terry; D Tolks; F Toti; J Tuomilehto; A Undeutsch; C Valadas; P Valensi; D Velickiene; P Vermunt; R Weiss; J Wens; T Yilmaz Journal: Horm Metab Res Date: 2010-04-13 Impact factor: 2.936
Authors: B Paulweber; P Valensi; J Lindström; N M Lalic; C J Greaves; M McKee; K Kissimova-Skarbek; S Liatis; E Cosson; J Szendroedi; K E Sheppard; K Charlesworth; A-M Felton; M Hall; A Rissanen; J Tuomilehto; P E Schwarz; M Roden; M Paulweber; A Stadlmayr; L Kedenko; N Katsilambros; K Makrilakis; Z Kamenov; P Evans; A Gilis-Januszewska; K Lalic; A Jotic; P Djordevic; V Dimitrijevic-Sreckovic; U Hühmer; B Kulzer; S Puhl; Y H Lee-Barkey; A AlKerwi; C Abraham; W Hardeman; T Acosta; M Adler; A AlKerwi; N Barengo; R Barengo; J M Boavida; K Charlesworth; V Christov; B Claussen; X Cos; E Cosson; S Deceukelier; V Dimitrijevic-Sreckovic; P Djordjevic; P Evans; A-M Felton; M Fischer; R Gabriel-Sanchez; A Gilis-Januszewska; M Goldfracht; J L Gomez; C J Greaves; M Hall; U Handke; H Hauner; J Herbst; N Hermanns; L Herrebrugh; C Huber; U Hühmer; J Huttunen; A Jotic; Z Kamenov; S Karadeniz; N Katsilambros; M Khalangot; K Kissimova-Skarbek; D Köhler; V Kopp; P Kronsbein; B Kulzer; D Kyne-Grzebalski; K Lalic; N Lalic; R Landgraf; Y H Lee-Barkey; S Liatis; J Lindström; K Makrilakis; C McIntosh; M McKee; A C Mesquita; D Misina; F Muylle; A Neumann; A C Paiva; P Pajunen; B Paulweber; M Peltonen; L Perrenoud; A Pfeiffer; A Pölönen; S Puhl; F Raposo; T Reinehr; A Rissanen; C Robinson; M Roden; U Rothe; T Saaristo; J Scholl; P E Schwarz; K E Sheppard; S Spiers; T Stemper; B Stratmann; J Szendroedi; Z Szybinski; T Tankova; V Telle-Hjellset; G Terry; D Tolks; F Toti; J Tuomilehto; A Undeutsch; C Valadas; P Valensi; D Velickiene; P Vermunt; R Weiss; J Wens; T Yilmaz Journal: Horm Metab Res Date: 2010-04-13 Impact factor: 2.936
Authors: Jaana Lindström; Pirjo Ilanne-Parikka; Markku Peltonen; Sirkka Aunola; Johan G Eriksson; Katri Hemiö; Helena Hämäläinen; Pirjo Härkönen; Sirkka Keinänen-Kiukaanniemi; Mauri Laakso; Anne Louheranta; Marjo Mannelin; Merja Paturi; Jouko Sundvall; Timo T Valle; Matti Uusitupa; Jaakko Tuomilehto Journal: Lancet Date: 2006-11-11 Impact factor: 79.321
Authors: Amaia Calderón-Larrañaga; Luis A Gimeno-Feliu; Rosa Macipe-Costa; Beatriz Poblador-Plou; Daniel Bordonaba-Bosque; Alexandra Prados-Torres Journal: BMC Public Health Date: 2011-06-06 Impact factor: 3.295
Authors: Jeffrey A Katula; Mara Z Vitolins; Erica L Rosenberger; Caroline S Blackwell; Timothy M Morgan; Michael S Lawlor; David C Goff Journal: Diabetes Care Date: 2011-05-18 Impact factor: 19.112
Authors: Ethan M Balk; Amy Earley; Gowri Raman; Esther A Avendano; Anastassios G Pittas; Patrick L Remington Journal: Ann Intern Med Date: 2015-09-15 Impact factor: 25.391
Authors: Linda Penn; Martin White; Jaana Lindström; Annemieke Th den Boer; Ellen Blaak; Johan G Eriksson; Edith Feskens; Pirjo Ilanne-Parikka; Sirkka M Keinänen-Kiukaanniemi; Mark Walker; John C Mathers; Matti Uusitupa; Jaakko Tuomilehto Journal: PLoS One Date: 2013-02-25 Impact factor: 3.240